GO
Loading...

Enter multiple symbols separated by commas

GlaxoSmithKline PLC

More

  • Pfizer Inc, the largest U.S. drugmaker, for example reported more than $234.2 million in research payments and another $53.3 million in general payments. John Diliberti, a pediatric geneticist from Illinois, collected nearly $447,000 from Pfizer in consulting fees last year, the biggest single payment to an individual doctor by the drugmaker.

  • Panel gives weak endorsement of new meningitis shots Wednesday, 24 Jun 2015 | 12:44 PM ET

    NEW YORK— A federal panel gave a weak endorsement Wednesday to two expensive meningitis shots, declining to recommend that all teens get the vaccine and leaving the decision to parents and doctors. At a meeting in Atlanta, the panel approved a half-measure that says older teens and young adults may get the shots— if they and their parents want to take that step.

  • Philip Morris International Inc has hired more than 400 scientists and technical staff at its research facility in Neuchatel, Switzerland, including toxicologists, chemists, biologists, biostatisticians and regulatory affairs experts. Altria Group Inc, makers of Marlboro, has recruited dozens of scientific and healthcare experts, as have independent...

  • LONDON, June 22- GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis. The British drugmaker said on Monday that the total consideration for the sale of its Nimenrix and Mencevax products to Pfizer's Irish unit, including some deferred payments, was...

  • LONDON/ BEIJING, June 18- A British corporate investigator freed from a Chinese jail last week has accused officials there of deliberately withholding medical treatment to try to force him to confess to a role in a scandal involving drugmaker GlaxoSmithKline Plc. Peter Humphrey and his American wife Yu Yingzeng returned to Britain on Wednesday evening after...

  • ZURICH, June 18- Novartis AG said on Thursday it expects to increase its profit margin this year as it restructures its drug portfolio and cuts costs, as well as generate cash for a higher dividend and smaller, strategic acquisitions. Novartis, the world's biggest supplier of prescription drugs by sales, is briefing investors about prospects at its research...

  • *Guinea trial last chance to show vaccine efficacy. LONDON, June 17- Drugmakers' plans to conduct vast clinical trials to test and hopefully validate the first Ebola vaccines have been thwarted by success in beating back the deadly epidemic in West Africa. The haemorrhagic Ebola virus has killed more than 11,000 people in Guinea, Sierra Leone and Liberia in an...

  • NEW YORK, June 11- A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits. Plaintiff Rachel Robinson claimed in her 2011 lawsuit that Pfizer failed to warn that using Zoloft during pregnancy...

  • China graft probes a tough tonic as pharma margins bounce Wednesday, 10 Jun 2015 | 5:00 PM ET

    Faster growth in China is good news for local and global firms chasing a medicine bill estimated by IMS Health to hit $185 billion by 2018, but who have taken a hit from a series of bribery probes that led to a $500 million fine against British drugmaker GlaxoSmithKline PLC last year. "Sales departments did slow down activities in China and have taken their time to...

  • SHANGHAI, June 9- A British corporate investigator linked to a bribery scandal in China involving drugmaker GlaxoSmithKline PLC is to be released early from a 2 1/ 2- year sentence in a Chinese jail, a source close to his family said on Tuesday. The case was intertwined with an investigation of GSK in China which rocked the country's pharmaceutical market and led...

  • CHICAGO/ NEW YORK, May 22- As a virulent avian influenza outbreak continues to spread across the Midwestern United States, some egg-dependent companies are contemplating drastic steps- importing eggs from overseas or looking to egg alternatives. A spokeswoman for Archer Daniels Midland Co said that as egg supplies tighten and prices rise, the food processing...

  • CHICAGO and NEW YORK, May 22- As a virulent avian influenza outbreak continues to spread across the Midwestern United States, some egg-dependent companies are contemplating drastic steps: importing eggs from overseas or looking to egg alternatives. "Canada is short on eggs and has been buying heavily from the U.S. for the last several years," said Rick Brown, a...

  • May 20- U.S. healthcare conglomerate Johnson& Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of daratumumab for the blood cancer multiple myeloma in the United...

  • NEW YORK, May 20- U.S. healthcare conglomerate Johnson& Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of the experimental drug daratumumab for the blood cancer...

  • *Tax officials say warned Finance Ministry since September. *Row with investors caused sell-off in India stocks, bonds. MUMBAI, May 19- India's Finance Ministry could have sidestepped a damaging multibillion-dollar tax row with foreign investors if it had acted on regular warning letters that officials had been sending since as long ago as September.

  • Steel producers help Europe stocks end higher Thursday, 14 May 2015 | 12:53 PM ET
    Pedestrians carry shopping bags in San Francisco.

    European equities ended higher as new regulation from the European Commission helped the continent's steel producers post strong gains.

  • *FTSE 100 down 0.1 pct, in line with Europe. LONDON, May 14- Britain's blue-chip FTSE 100 index edged down on Thursday- broadly in line with European shares, hit by a persistent bond-market sell-off- after a mixed bag of corporate earnings and weaker commodity prices. "U.S. and UK stocks appear to be preferred versus German stocks for now, mainly because any increases in...

  • LONDON, May 14- Companies that develop new antibiotics should be awarded prize money of up to $3.5 billion for each new drug, instead of selling the medication at a profit, a review backed by Britain's government said on Thursday. The review, lead by former Goldman Sachs chief economist Jim O'Neill, said the lump sum payments could add up to $16- $37 billion over 10...

  • GSK, US experts team up to find cure for AIDS Monday, 11 May 2015 | 9:22 AM ET
    AIDS, HIV, Africa

    Britain's GlaxoSmithKline is to collaborate with U.S. scientists in developing a cure for AIDS.

  • Early movers: DISH, ACT, ROSE, HLT, BID & more Monday, 11 May 2015 | 7:50 AM ET
    Trader on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.